The present invention relates to 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophe-noxy]-N-methylpyridine-2-carboxamide monohydrate, to processes for itspreparation, to pharmaceutical compositions comprisingit and to its use in the control of disorders.